[Abstract] [Full Text HTML] [Full Text PDF] (in Japanese / 5505KB) [PDF: Members Only]

J.Jpn. Surg. Soc.. 123(3): 255-261, 2022


Feature topic

CURRENT STATUS AND FUTURE DIRECTION OF MULTIMODAL MANAGEMENT OF LOCALLY RECURRENT RECTAL CANCER

Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan

Kay Uehara, Atsushi Ogura, Yuki Murata, Nobuyuki Watanabe, Maki Sunagawa, Shunsuke Onoe, Kazushi Miyata, Junpei Yamaguchi, Takashi Mizuno, Tsuyoshi Igami, Toshio Kokuryo, Yukihiro Yokoyama, Tomoki Ebata

In the treatment of locally recurrent rectal cancer, it is widely accepted that surgical resection is the only potential measure for cure. Extended surgery is required in most patients; however, local control and survival are unsatisfactory. For further improvement of the outcome, not only surgical techniques but also knowledge and experience of recently developed multimodal treatment are essential. Due to the nature of the disease, it is difficult to obtain clear evidence from randomized, controlled trials, and therefore treatment strategies must depend on the experience at center facilities. In this article, we describe the current status and future prospects of locally recurrent rectal cancer treatment in Japan and Western countries.


<< To previous pageTo next page >>

To read the PDF file you will need Adobe Reader installed on your computer.